Journal article
GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials
Survey of ophthalmology, v 68(6), pp 1071-1083
01 Nov 2023
PMID: 37454782
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are used to treat type 2 diabetes mellitus. Recent research suggests that GLP-1 RAs may influence diabetic retinopathy (DR). We searched ClinicalTrials.gov for trials comparing FDA-approved GLP-1 RAs to placebo, insulin, or oral antidiabetic medicine. Rates of DR, ocular adverse events, demographics, and clinical characteristics were compared amongst cohorts on 93 trials. GLP-1 RA use was significantly associated with increased risk of early-stage DR (risk ratio (RR) = 1.31, 95% confidence interval (CI) [1.01, 1.68]) and early-stage retinal adverse events (RR = 1.29, 95% CI [1.01, 1.66]) compared to placebo. Compared to insulin, GLP-1 RA use protected against late-stage DR (RR = 0.38, 95% CI [0.15, 0.98]). Analysis of individual GLP-1 RAs showed that albiglutide is responsible for these trends, as it is significantly associated with a higher risk of early-stage DR (RR = 2.18, 95% CI [1.01, 4.67]) compared to placebo and a lower risk of late-stage DR (RR = 0.25, 95% CI [0.09, 0.70]) compared to insulin. Albiglutide similarly affected retinal and ocular adverse events. Demographic analysis revealed significant differences between GLP-1 RA and comparator groups for age, HbA1c, body weight, BMI, duration of diabetes, sex, race, and ethnicity. The influence of GLP-1 RAs on DR and the eye may depend on the specific GLP-1 RA and patient demographic and clinical characteristics.
Metrics
1 Record Views
Details
- Title
- GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials
- Creators
- Ishani Kapoor - Drexel UniversitySwara M. Sarvepalli - Central Michigan UniversityDavid D'Alessio - Duke UniversityDilraj S. Grewal - Duke UniversityMajda Hadziahmetovic - Duke University
- Publication Details
- Survey of ophthalmology, v 68(6), pp 1071-1083
- Publisher
- Elsevier
- Number of pages
- 13
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- College of Medicine
- Web of Science ID
- WOS:001083167000001
- Scopus ID
- 2-s2.0-85167798475
- Other Identifier
- 991022197288404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
Source: SDGs in the Output
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Ophthalmology